The NF-κB is constitutively activated in a variety of hematologic and solid malignancies, including pancreatic cancer and controls the expression of an array of genes involved in cell proliferation and survival through direct and indirect mechanisms [18]–[20]. This evidence concerns the gene NFKB1 and pancreatic neoplasm.